US › Healthcare

Si-Bone Inc (SIBN)

US · Healthcare · Medical Devices

$18.44-0.05%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$52.6M
Revenue YoY
+11.2%
Net profit
$-4.3M
Profit YoY
+33.8%
EPS
$-0.10
EPS estimate
$-0.19
Net margin
-8.2%

EPS came in at -0.10 against a street estimate of -0.19 — a beat of 47.4%.

Key statistics

Market cap
$818.2M
Forward P/E
0.0
P/B
4.40
Book value
$4.05
EPS (TTM)
$-0.39
52-week high
$21.89
52-week low
$11.48
50-day MA
$16.16
200-day MA
$16.00
Beta
0.70

Analyst view

Analysts rate Si-Bone Inc a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $24.44.

Shareholding

Insiders
3.42%
Institutions
107.09%

Largest institutional holders

FundStake
First Light Asset Management, LLC12.07%
BlackRock Inc7.73%
American Century Companies Inc5.66%
Vanguard Group Inc5.64%
Brown Advisory Holdings Inc4.79%
Cadian Capital Management LP4.26%
Vanguard Capital Management, LLC3.98%
Granahan Investment Management Inc..3.92%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Si-Bone Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.